Aspergillus fumigatus enhances elastase production in Pseudomonas aeruginosa co-cultures

Medical Mycology

Volumn 53, Issue 7, 2015, Pages 645-655

  Smith, Karen ^a   Rajendran, Ranjith ^b   Kerr, Stephen ^b   Lappin, David F ^b   Mackay, William G ^a   Williams, Craig ^a   Ramage, Gordon ^b  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^b GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

Aspergillus; biofilms; cystic fibrosis; elastase; Pseudomonas

Indexed keywords

CONGO RED; ELASTASE; BACTERIAL PROTEIN; CULTURE MEDIUM; METALLOPROTEINASE; PSEUDOLYSIN, PSEUDOMONAS AERUGINOSA;

ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOFILM; COCULTURE; CYSTIC FIBROSIS; ENZYME SYNTHESIS; FILAMENTOUS FUNGUS; FUNGUS GROWTH; HUMAN; HUMAN CELL; LUNG PARENCHYMA; MASS SPECTROMETRY; NONHUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; SUPERNATANT; ASPERGILLOSIS; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; CHEMISTRY; CHILD; COMPLICATION; CULTURE MEDIUM; DRUG EFFECTS; ENZYMOLOGY; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; ORGANISMAL INTERACTION; PHYSIOLOGY; PRESCHOOL CHILD; PSEUDOMONAS INFECTION; SECRETION (PROCESS);

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACTERIAL PROTEINS; CELL LINE; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; CYSTIC FIBROSIS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; MASS SPECTROMETRY; METALLOENDOPEPTIDASES; MICROBIAL INTERACTIONS; MICROBIOLOGICAL TECHNIQUES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84941199899     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myv048     Document Type: Article

References (42)

1. Peters BM, Jabra-Rizk MA, O'May GA et al. Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev 2012; 25(1): 193-213.
2. Singer M. Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease. Virulence 2010; 1(1): 10-18.
3. Sheppard MN, Nicholson AG. Th e pathology of cystic fibrosis. Curr Diagn Pathol 2010; 8: 50-59.
4. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168(8): 918-951.
5. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology 2007; 153(4): 917-923.
6. Valenza G,Tappe D,Turnwald D,et al. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis J Cyst Fibros 2008, 7, 2, 123-127.
7. Huang YJ, Lynch SV. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med 2011; 5(6): 809-821.
8. Price KE, Hampton TH, Gifford AH et al. Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome 2013; 1(1): 27.
9. Stressmann FA, Rogers GB, van der Gast CJ et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 2012; 67(10): 867-873.
10. Bakare N, Rickerts V, Bargon J et al. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003; 46 (1-2): 19-23.
11. Yang L, Liu Y, Wu H et al. Current understanding of multispecies biofilms. Int J Oral Sci 2011; 3 (2): 74-81.
12. Duan K, Dammel C, Stein J et al. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 2003; 50 (5): 1477-1491.
13. Mo wat E, Rajendran R, Williams C et al. Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol Lett 2010; 313 (2): 96-102.
14. Goss CH, Burns JL. Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax 2007; 62 (4): 360-367.
15. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002; 15 (2): 194-222.
16. Lee DG, Urbach JM, Wu G et al. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol 2006; 7 (10): R90.
17. Azghani AO. Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. Am J Respir Cell Mol Biol 1996; 15 (1): 132-140.
18. Alcorn JF,Wright JR. Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J Biol Chem 2004; 279 (29): 30871-30879.
19. Jacquot J, Tournier JM, Puchelle E. In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase. Infect Immun 1985; 47 (2): 555-560.
20. Kuang Z, Hao Y, Walling BE et al. Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A. PLoS One 2011; 6 (11): e27091.
21. Theander TG, Kharazmi A, Pedersen BK et al. Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases. Infect Immun 1988; 56 (7): 1673-1677.
22. Cathcart GR, Quinn D, Greer B et al. Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection. Antim icrob. Agents Chemother. 2011; 55 (6): 2670-2678.
23. Hamood AN,Griswold J, Colmer J. Characterization of elastasedeficient clinical isolates of Pseudomonas aeruginosa. Infect Immun 1996; 64 (8): 3154-3160.
24. Schad PA, Bever RA, Nicas TI et al. Cloning and characterization of elastase genes from Pseudomonas aeruginosa. J Bacteriol 1987; 169 (6): 2691-2696.
25. Be'er A, Ariel G, Kalisman O et al. Lethal protein produced in response to competition between sibling bacterial colonies. Proc Natl Acad Sci U S A 2010; 107 (14): 6258-6263.
26. Mowat E, Butcher J, Lang S et al. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol 2007; 56 (9): 1205-1212.
27. Savli H,Karadenizli A,Kolayli F,et al. Expression stability of six housekeeping genes: A proposal for resistance gene quantification studies of Pseudomonas aeruginosa by real-time quantitative RT-P CR J Med Microbiol 2003 52,5, 403-408.
28. Bever RA, Iglewski BH. Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene. J Bacteriol 1988; 170 (9): 4309-4314.
29. Emerson J, Rosenfeld M, McNamara S et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pul monol 2002; 34 (2): 91-100.
30. Nixon GM, Armstrong DS, Carzino R et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001; 138 (5): 699-704.
31. Delhaes L, Monchy S, Frealle E et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management. PLoS One 2012; 7 (4): e36313.
32. Sibley CD, Parkins MD, Rabin HR et al. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A 2008; 105 (39): 15070-15075.
33. Sibley CD, Surette MG. The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. Can J Microbiol 2011; 57 (2): 69-77.
34. Bargon J, Dauletbaev N, Kohler B et al. Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. Respir Med 1999; 93 (11): 835-838.
35. de Vrankrijker AM, van der Ent CK, van Berkhout FT et al. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? Clin Microbiol Infect 2011; 17 (9): 1381-1386.
36. Amin R, Dupuis A, Aaron SD et al. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 2010; 137 (1): 171-176.
37. Antunes LC, Ferreira RB, Buckner MM et al. Quorum sensing in bacterial virulence. Microbiology 2010; 156 (8): 2271-2282.
38. Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 2004; 54 (5): 1212-1223.
39. Trejo-Hernandez A, Andrade-Dominguez A, Hernandez M et al. Inters pecies competition triggers virulence and mutability in Candida albicans-Pseudomonas aeruginosa mixed biofilms. ISME J 2014; 8 (10): 1974-1988.
40. Nomura K, Obata K, Keira T et al. Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells. Respir Res 2014; 15: 21 .
41. Nicas TI, Iglewski BH. Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa. J. Clin Microbiol 1986; 23 (5): 967-969.
42. Feg an M, Francis P, Hayward AC et al. Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis. J Clin Microbiol 1990; 28 (6): 1143-1146.